<DOC>
	<DOCNO>NCT02616224</DOCNO>
	<brief_summary>This observational disease registry prospective , national , non-interventional study design enroll participant receive initial diagnosis unresectable , locally advanced ( LA ) metastatic breast cancer ( mBC ) , 6 month prior registry enrolment . These participant prospectively follow least 5 year study enrolment evaluate anti-cancer treatment . Data participant ' previous anti-cancer treatment breast cancer collect retrospectively study entry .</brief_summary>
	<brief_title>A Study To Observe Treatment Patterns Outcomes Patients With HER2-Positive Unresectable Locally Advanced Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Initially diagnose HER2positive unresectable LA/mBC 6 month prior enrolment , although received anticancer treatment time There exclusion criterion entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>